BackPharming Group N.V. Overview

Pharming Group N.V. Goodwill

Pharming Group N.V.'s goodwill is $0.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

Pharming Group N.V. Goodwill History

Loading

Pharming Group N.V. vs. peers: Goodwill Comparison

Loading

Pharming Group N.V. Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Pharming Group N.V. (PHAR) FAQ

As of the most recent data (June 2026), PHAR shows a goodwill of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PHAR's goodwill is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Pharming Group N.V. is outperforming or lagging.

Tracking PHAR's goodwill over time shows whether Pharming Group N.V. is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Pharming Group N.V.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $0) with ownership activity and broader fundamentals.

Pharming Group N.V.'s goodwill is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.